Protalix BioTherapeutics
PLX
#8648
Rank
ยฃ61.64 M
Marketcap
ยฃ0.84
Share price
-4.35%
Change (1 day)
-39.70%
Change (1 year)

Protalix BioTherapeutics (PLX) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : ยฃ47.97 M

According to Protalix BioTherapeutics 's latest financial reports the company's total liabilities are ยฃ47.97 M. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Protalix BioTherapeutics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31ยฃ39.92 M-27.29%
2022-12-31ยฃ54.9 M-6.76%
2021-12-31ยฃ58.89 M-15.35%
2020-12-31ยฃ69.56 M-20.22%
2019-12-31ยฃ87.19 M-2.42%
2018-12-31ยฃ89.35 M18.78%
2017-12-31ยฃ75.22 M0.67%
2016-12-31ยฃ74.72 M28.33%
2015-12-31ยฃ58.22 M-32.33%
2014-12-31ยฃ86.05 M1.31%
2013-12-31ยฃ84.94 M67.33%
2012-12-31ยฃ50.76 M1.3%
2011-12-31ยฃ50.1 M1.37%
2010-12-31ยฃ49.43 M-4.15%
2009-12-31ยฃ51.57 M1050.46%
2008-12-31ยฃ4.48 M101.06%
2007-12-31ยฃ2.22 M61.52%
2006-12-31ยฃ1.38 M110.67%
2005-12-31ยฃ0.65 M1670.28%
2004-12-31ยฃ0.03 M-16.72%
2003-12-31ยฃ0.04 M-9.88%
2002-12-31ยฃ0.04 M-7.47%
2001-12-31ยฃ0.05 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
ยฃ0.47 B 879.94%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.60 B 1,164.00%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ97.69 B 203,553.17%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ26.49 B 55,134.36%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel